[Form 4] Olaplex Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Olaplex Holdings director Deirdre Findlay was granted 110,294 restricted stock units (RSUs) under the company's 2021 Equity Incentive Plan, reported on Form 4. Each RSU represents the conditional right to one share of common stock and was recorded as an acquisition on 08/12/2025 at no cash price. The RSUs will vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, contingent on the reporting person's continued service through the vesting date. The filing was signed by an attorney-in-fact on 08/14/2025 and includes a Power of Attorney exhibit.

Positive

• Grant aligns director incentives by tying compensation to long‑term equity through RSUs that vest at the 2026 Annual Meeting
• Substantial award recorded: 110,294 RSUs increase the reporting person's beneficial holdings to 248,693 shares, showing meaningful director stake

Negative

• Potential dilution when 110,294 RSUs convert into common shares upon vesting
• Vesting contingent on continued service, so retention risk exists if the director departs before the 2026 Annual Meeting

Insights

Corporate Governance Expert

TL;DR: Director received time‑based RSUs that align incentives with shareholder value over the next year.

The grant of 110,294 RSUs is a standard form of equity compensation for non‑employee or director service, tying long‑term interests to equity performance through a full vesting event at the 2026 Annual Meeting. This structure encourages retention and aligns the director with shareholders through continued service rather than immediate cash payout. The filing shows no immediate cash cost to the reporting person and a single vesting milestone.

Securities Analyst

TL;DR: Material number of RSUs recorded; impacts share count upon vesting but no immediate sale or cash transaction.

The Form 4 reports an acquisition of 110,294 RSUs at $0 on 08/12/2025, increasing the reporting person's beneficial holdings to 248,693 shares post‑grant. These RSUs convert to common stock upon vesting, which will increase the issuer's outstanding shares then outstanding. There is no derivative activity or option exercise reported, and the grant carries a single vesting condition tied to continued service through the 2026 Annual Meeting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Findlay Deirdre

(Last) (First) (Middle)

C/O OLAPLEX HOLDINGS, INC.

432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		A		110,294(1)	A	$0	248,693	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ John Duffy, attorney-in-fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Olaplex (OLPX) report in this Form 4?

The Form 4 reports that director Deirdre Findlay was granted 110,294 RSUs on 08/12/2025 under the 2021 Equity Incentive Plan, each representing one share and vesting in full at the 2026 Annual Meeting.

When will the RSUs granted to Deirdre Findlay vest?

The RSUs will vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, subject to continued service through that date.

Did the reporting person pay for the RSUs?

No cash was reported; the transaction is listed with a price of $0, representing a grant of restricted stock units rather than a purchase.

How many shares will the reporting person beneficially own after the grant?

Following the reported transaction, the filing shows the reporting person beneficially owns 248,693 shares (including the 110,294 RSUs).

Is there any derivative activity or option exercise in this filing?

No. Table II (derivative securities) shows no reported activity; the filing documents only a non‑derivative RSU grant in Table I.